Steven L Highfill - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Steven L Highfill

Showing results (51-60 of 57) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 57 results.

Blood|September 15, 2021

Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cellsDaniel A Lichtenstein, Fiorella Schischlik, Lipei Shao, et al.

Cell Reports. Medicine|September 29, 2023

Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcomaMeijie Tian, Jun S Wei, Nityashree Shivaprasad, et al.

Cell Reports. Medicine|May 9, 2024

Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcomaMeijie Tian, Jun S Wei, Nityashree Shivaprasad, et al.

Cell|May 1, 2026

Distinct in vivo dynamics of donor-derived stem cell memory CAR T cells post-allogeneic HSCT relapseLuca Gattinoni, Gabriele Inchingolo, Dennis C Harrer, et al.

Blood|May 23, 2022

CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CARHaneen Shalabi, Haiying Qin, Angela Su, et al.

Nature Medicine|April 23, 2021

Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cellsNathan Singh, Noelle V Frey, Boris Engels, et al.

Cancer Cell|December 22, 2023

Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapySabina Kaczanowska, Tara Murty, Ahmad Alimadadi, et al.

Pageof 6

Search research articles

Showing results (51-60 of 57) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 57 results.

Blood|September 15, 2021

Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cellsDaniel A Lichtenstein, Fiorella Schischlik, Lipei Shao, et al.

Cell Reports. Medicine|September 29, 2023

Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcomaMeijie Tian, Jun S Wei, Nityashree Shivaprasad, et al.

Cell Reports. Medicine|May 9, 2024

Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcomaMeijie Tian, Jun S Wei, Nityashree Shivaprasad, et al.

Cell|May 1, 2026

Distinct in vivo dynamics of donor-derived stem cell memory CAR T cells post-allogeneic HSCT relapseLuca Gattinoni, Gabriele Inchingolo, Dennis C Harrer, et al.

Blood|May 23, 2022

CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CARHaneen Shalabi, Haiying Qin, Angela Su, et al.

Nature Medicine|April 23, 2021

Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cellsNathan Singh, Noelle V Frey, Boris Engels, et al.

Cancer Cell|December 22, 2023

Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapySabina Kaczanowska, Tara Murty, Ahmad Alimadadi, et al.

Pageof 6